<?xml version="1.0"?>
<law><section_number>46.13</section_number><edition_id>1</edition_id><section_id>1891</section_id><structure_id>44</structure_id><catch_line>Disclosure Of Hazards.</catch_line><history></history><full_text>&#xA0; DISCLOSURE OF HAZARDS.

	No over-the-counter drug containing caffeine, ephedrine or phenylpropanolamine shall be displayed or offered for sale, or sold unless there appears on the package or container in which said drug is displayed or offered for sale, or sold, a label stating &#x201C;WARNING, DO NOT EXCEED THE RECOMMENDED DOSAGE FOR THIS DRUG AS STATED ON THE LABEL&#x201D;. Such warning shall be in red lettering.</full_text><order_by>13</order_by><ancestry><unit id="44" label="article"><name>Regulation Of Over-The-Counter Drugs</name><identifier>6.5</identifier><url>/4/6.5/</url></unit><unit id="11" label="chapter"><name>Public Welfare</name><identifier>4</identifier><url>/4/</url></unit></ancestry><structure_contents><unit id="3656"><structure_id>44</structure_id><section_number>46.10</section_number><catch_line>Definitions.</catch_line><url>/46.10/</url><token>46.10</token></unit><unit id="2236"><structure_id>44</structure_id><section_number>46.11</section_number><catch_line>Over-The-Counter Drugs Resembling Dangerous Drugs &#x2013; Sale Prohibited.</catch_line><url>/46.11/</url><token>46.11</token></unit><unit id="78"><structure_id>44</structure_id><section_number>46.12</section_number><catch_line>Misrepresentation As A Dangerous Drug.</catch_line><url>/46.12/</url><token>46.12</token></unit><unit id="1891"><structure_id>44</structure_id><section_number>46.13</section_number><catch_line>Disclosure Of Hazards.</catch_line><url>/46.13/</url><token>46.13</token></unit><unit id="3454"><structure_id>44</structure_id><section_number>46.14</section_number><catch_line>Disclosure Of Contents.</catch_line><url>/46.14/</url><token>46.14</token></unit><unit id="2523"><structure_id>44</structure_id><section_number>46.15</section_number><catch_line>Exception.</catch_line><url>/46.15/</url><token>46.15</token></unit></structure_contents><next_section id="3454"><structure_id>44</structure_id><section_number>46.14</section_number><catch_line>Disclosure Of Contents.</catch_line><url>/46.14/</url><token>46.14</token></next_section><metadata></metadata><references></references><url>/46.13/</url><token>46.13</token><formats><txt>/46.13.txt</txt><json>/46.13.xml</json></formats><dublin_core><Title>Disclosure Of Hazards.</Title><Type>Text</Type><Format>text/html</Format><Identifier>&#xA7; 46.13</Identifier><Relation>Los Angeles Municipal Code</Relation></dublin_core><plain_text>                            LOS ANGELES MUNICIPAL CODE

DISCLOSURE OF HAZARDS. (&#xA7; 46.13)

&#xA0; DISCLOSURE OF HAZARDS.	No over-the-counter drug containing caffeine,
ephedrine or phenylpropanolamine shall be displayed or offered for sale, or sold
unless there appears on the package or container in which said drug is displayed
or offered for sale, or sold, a label stating &#x201C;WARNING, DO NOT EXCEED THE
RECOMMENDED DOSAGE FOR THIS DRUG AS STATED ON THE LABEL&#x201D;. Such warning shall
be in red lettering.
</plain_text><html>
					&lt;section&gt;&lt;p&gt;&#xA0; DISCLOSURE OF HAZARDS.&lt;br /&gt;&lt;br /&gt;	No over-the-counter drug containing caffeine, ephedrine or phenylpropanolamine shall be displayed or offered for sale, or sold unless there appears on the package or container in which said drug is displayed or offered for sale, or sold, a label stating &#x201C;WARNING, DO NOT EXCEED THE RECOMMENDED DOSAGE FOR THIS DRUG AS STATED ON THE LABEL&#x201D;. Such warning shall be in red lettering.&lt;/p&gt;&lt;/section&gt;</html><previous_section id="78"><structure_id>44</structure_id><section_number>46.12</section_number><catch_line>Misrepresentation As A Dangerous Drug.</catch_line><url>/46.12/</url><token>46.12</token></previous_section><text><unit id="1875" prefix=""><text>&#xA0; DISCLOSURE OF HAZARDS.	No over-the-counter drug containing caffeine, ephedrine or phenylpropanolamine shall be displayed or offered for sale, or sold unless there appears on the package or container in which said drug is displayed or offered for sale, or sold, a label stating &#x201C;WARNING, DO NOT EXCEED THE RECOMMENDED DOSAGE FOR THIS DRUG AS STATED ON THE LABEL&#x201D;. Such warning shall be in red lettering.</text><type>section</type><prefixes><unit></unit></prefixes><entire_prefix></entire_prefix><prefix_anchor></prefix_anchor><level>1</level></unit></text></law>
